Melatonin, Etkileri ve Kullanım Alanları
Yıl 2017,
Cilt: 28 Sayı: 1, 7 - 12, 15.06.2017
Ayris Salt
Metin Çenesiz
,
Sena Çenesiz
Öz
Melatonin günlük ve mevsimsel değişiklik gösterebilen pineal bezden salgılanan ve suprakiazmatik nukleus tarafından endojen ritmi düzenleyen bir hormondur. Günümüzde tıp ve veteriner hekimlikte ekzojen kullanım alanlarının genişlemesi bu hormonun önemini arttırmıştır. Hücresel kompartmanlara kolayca geçebilen bu hormon güçlü bir antioksidan özellik göstermekle beraber, sirkadyen ritmi düzenleyerek vücutta homeostazisi sağlar. Bağışıklık sistemi üzerine de olumlu etkileri bulunmaktadır. Bazı hayvan türlerinde de üreme siklusunu başlatıcı ya da inhibe edici etki gösterir. Yapılan çalışmalarla melatoninin antikanserojenik etkinliği ortaya koyulmuştur. Bu derlemede melatoninin biyokimyasal özellikleri ile kullanım alanları anlatılmaktadır.
Kaynakça
- 1. Alkan S, Horoz H, Kaşıkçı G, Sönmez C, Ak K, (2003).
Kısraklarda Üreme Mevsiminin Farklı Dönemlerinde
Vaginal Progesteron Uygulamalarının Fertiliteye Etkisi.
İstanbul Üniversitesi Veteriner Fak Derg. 29(1), 111-17.
2. Altun A, Yaprak M, Vardar A, Aktoz M, Özbay G, (2001).
Decreased nocturnal melatonin secretion in coronary artery
disease (abstr). J Coronary Artery Dis. 4: 108.
3. Bendz LM, Scates AC, (2010). Melatonin Treatment for
Insomnia in Pediatric patients with Attention-Deficit/
Hyperactivity Disorder. Ann Pharmacother. 44(1), 185-91.
4. Beyer CE, Steketee JD, Saphier D, (1998). Antioxidant
properties of melatonin--an emerging mystery. Biochem
Pharmacol. 56(10), 1265-1272.
5. Canoğlu E, Sarıbay K, (2012). Koyun ve keçilerde doğum ve
jinekoloji. Semacan A, Kaymaz M, Fındık M, Rişvanlı A,
Köker A. eds. Çiftlik hayvanlarında doğum ve jinekoloji.
Malatya, Medipres Maatbacılık, Malatya. p.521-649.
6. Claustrat B, Brun J, Chazot G, (2005). The basic physiology
and pathophysiology of melatonin. Sleep Med Rev. 9:
11–24.
7. Claustrat B, Geoffriau M, Brun J, Chazot G, (1995).
Melatonin in humans: a biochemical marker of the circadian clock and an endogenous synchronizer. Neurophysiol
Clin. 25(6):351-359.
8. Crowell-Davis SL, (2007). Sexual behavior of mares. Horm
Behav. 52, 12–17.
9. Czeisler CA, Shanahan TL,Klerman EB, Martens H, Brotman
DJ, Emens JS, Klein T, Rizzo JF 3rd (1995). Suppression of
melatonin secretion in some blind patients by exposure to
bright light. N Engl J Med. 332(1), 6–11.
10. Dubocovich ML, Markowska M, (2005). Functional MT1
and MT2 melatonin receptors in mammals. Endocrine. 27,
101-110.
11. Fiorina P, Lattuada G, Silvestrini C, Ponari O, Dall’Aglio
P, (1999) Disruption of nocturnal melatonin rhythm and
immunological involvement in ischaemic stroke patients.
Scand J Immunol. 50(2), 228–231.
12. Ghosh D, Paul S, Naaz S, Bhowmik D, Dutta M, Ghosh AK,
Firdaus SD, Chattopadhyay A, Reiter RJ, Bandyopadhyay
D, (2016). Melatonin protects against lead acetate induced
oxidative stress-mediated changes in morphology and metabolic
status in rat red blood cells: a flow cytometric and
biochemical analysis. J Pharm Res.10(6) ,381-402.
13. Hardeland R, Reiter RJ, Poeggeler B, Tan D-X, (1993). The
significance of the metabolism of the neurohormone melatonin:
Antioxidative protection and formation of bioactive
substances. Neurosci Biobehav Rev. 17, 347-357.
14. K-Laflamme A, Wu L, de Champlain J, (1998). Impaired
basal sympathetic tone and alpha 1-adrenergic responsiveness
in association with the hypotensive effect of melatonin
in spontaneously hypertensive rats. Am J Hypertens. 11,
219-29.
15. Koçak A, Çolak A, (1996). Melatonin ve Santral Sinir
Sistemi. Turgut Özal Tıp Merkezi Dergisi. 3(3), 237-244.
16. Kutzler MA, (2015). Alternative methods for feline fertility
control: Use of melatonin to suppress reproduction. J Feline
Med Surg. 17, 753–757
17. Liu J, Clough SJ, Hutchinson AJ, Adamah-Biassi EB,
Gorevski MP, and Dubocovich ML, (2016). MT1 and MT2
Melatonin Receptors: A Therapeutic Perspective. Annu.
Rev. Pharmacol. Toxicol. 56, 361-383.
18. Lusardi P, Preti P, Savino S, Piazza E, Zoppi E, Fogari R,
(1997). Effect of bedtime melatonin ingestion on blood
pressure of normotensive subjects. Blood Press Monit. 2,
99- 103.
19. Molina-Carballo A, Muñoz-Hoyos A, Reiter RJ, Sánchez-
Forte M, Moreno-Madrid F, Rufo-Campos M, Molina-Font
JA, Acuña-Castroviejo D, (1997). Utility of high doses of
melatonin as adjunctive anticonvulsant therapy in a child
with severe myoclonic epilepsy: two years’experience. J
Pineal Res. 23(2), 97–105.
20. Nagy P, Guillaume D, Daels P, (2000). Seasonality in mares.
Anim Reprod Sci. 60-61, 245-262.
21. Nosjean O, Ferro M, Coge F, Beauverger P, Henlin JM,
Lefoulon F, Fauchere JL, Delagrange P, Canet E, Boutin
JA, (2000). Identification of the melatonin-binding site
MT3 as the quinone reductase 2. J Biol Chem. 275 (40),
31311–31317.
22. Okur Gümüşova S, Memiş YS, (2014). Bazı Viral
Enfeksiyonlarda Melatoninin Etkileri. Atatürk Üniversitesi
Vet. Bil. Derg. 9(1), 50-54.
23. Özgüner F, Özcankaya R, Delibaş N, Koyu A, Çalışkan
S, (1995). Melatonin ve klinik önemi. SDÜ tıp fakültesi
Dergisi. 2(4), 1-6.
24. Öztürk L, Darıyerli N, (2000). Melatonin ve Uyku
Fizyolojisi. Türkiye Tıp Derg. 7(2), 104-109.
25. Özyurtlu N, Bademkıran S, (2010). Koyunlarda Östrus
Senkronizasyonu ve Östrusu Uyarma Yöntemleri. Dicle
Üniv Vet Fak Derg. 1(1), 17-22.
26. Pacchierotti C, Iapichino S, Bossini L, Pieraccini F,
Castrogiovanni P, (2001). Melatonin in Psychiatric
Disorders: A Review on the Melatonin Involvement in
Psychiatry. Front Neuroendocrinol. 22(1), 18-32.
27. Paulis L, Simko F, (2007). Blood pressure modulation and
cardiovascular protection by melatonin: potential mechanisms
behind. Physiol Res. 56, 671-684.
28. Peltier MR, Robinson G, Sharp DC, (1998a). Effects of
melatonin implants in pony mares. 2. Long-term effects.
Theriogenology. 49(6), 1125-1142.
29. Peltier MR, Robinson G, Sharp DC, (1998b). Effects
of melatonın ımplants ın pony mares. 1. Acute effects.
Theriogenology. 49(6), 1113-1123.
30. Provinciali M, Di Stefano G, Bulian D, Tibaldi A, and
Fabris N, (1996). Effect of melatonin and pineal grafting
on thymocyte apoptosis in aging mice. Mech Ageing Dev.
90(1), 1–19.
31. Reiter RJ, (1991a). Neuroendocrine effects of light. Int J
Biometeorol. 35, 169-175.
32. Reiter RJ, (1991b). Pineal melatonin: cell biology of its
synthesis and of its physiological interactions. Endocrine
Reviews. 12(2), 151–80.
33. Reiter RJ, Tan DX, Osuna C, Gitto E, (2000). Actions of
melatonin in the reduction of oxidative stress. J Biomed
Sci. 7, 444-458.
34. Rios ER, Venâncio ET, Rocha NF, Woods DJ, Vasconcelos
S, Macedo D, Sousa FC, Fonteles MM, (2010). Melatonin:
Pharmacological Aspects and Clinical Trends. Int J
Neurosci. 120(9), 583-590.
35. Satué K, Gardón JC, (2013). Review of the Estrous Cycle
and the Neuroendocrine Mechanisms in the Mare. J Steroids
Horm Sci. 4(2),115.
36. Sewerynek E. Melatonin and the cardiovascular system.
Neuro Endocrinol Lett. 23 Suppl 1, 79-83.
37. Simonneaux V, Ribelayga C, (2003). Generation of the
Melatonin Endocrine Message in Mammals: A Review
of the Complex Regulation of Melatonin Synthesis by
Norepinephrine, Peptides, and Other Pineal Transmitters.
Pharmacol Rev. 55(2), 325-395.
38. Slaugenhaupt SA, Roca AL, Liebert CB, Altherr MR,
Gusella JF, Reppert SM, (1995). Mapping of the gene
for the Mel1a-melatonin receptor to human chromosome
4 (MTNR1A) and mouse chromosome 8 (Mtnr1a).
Genomics. 27(2), 355–357.
39. Srinivasan V, Spence DW, Pandi-Perumal SR, Trakht I,
Cardinali DP, (2008). Jet lag: Therapeutic use of melatonin
and possible application of melatonin analogs. Travel Med
Infect Dis. 6(1-2), 17-28.
40. Topal T, Korkmaz A, (2009). Melatonin ve kanserle ilişkisi.
Genel Tıp Derg. 19(3), 137-143.
41. Touitou Y, Le Hoang P, Claustrat B, Attye T, Auzeby A,
Brun J, Bogdan A, Touitou C, (1986). Decreased nocturnal
plasma melatonin peak in patients with a functional alteration
of the retina in relation with uveitis. Neurosci Lett.
70(1), 170–174.
42. Uyar A, Alan M, (2008). Koyunlarda Erken Anöstrüs
Döneminde Melatonin Uygulamalarının Ovulasyon ve
Gebelik Üzerine Etkisi. YYÜ vet fak derg. 19(1), 47-54.
43. Waterhouse J, Reilly T, Atkinson G, Edwards B, (2007). Jet
lag: trends and coping strategies. Lancet. 369, 1117–1129.
44. Williams GL, Thorson JF, Prezotto LD, Velez IC, Cardoso
RC, Amstalden M, (2012). Reproductive seasonality in the
mare: neuroendocrine basis and pharmacologic control.
Domest Anim Endocrinol. 43(2), 103-115.
45. Witt-Enderby PA, Bennett J, Jarzynka MJ, Firestine S,
Melan MA, (2003). Melatonin receptors and their regulation:
biochemical and structural mechanisms. Life Sci. 72,
2183–2198.
46. Wurtman RJ, Axelrod J, Chu EW, (1963). Melatonin, a pineal
substance: Effect on the rat ovary. Science. 141, 277-
278.
47. Yazıcı C, Köse K, (2004). Melatonin: karanlığın antioksidan
gücü. E.Ü.Journal of Health Sciences. 13(2), 56-65.
48. Yonei Y, Hattori A, Tsutsui K, Okawa M, Ishizuka B,
(2010). Effects of Melatonin: Basics Studies and Clinical
Applications. Anti-Aging Medicine. 7(7), 85-89.